Assessment of the hypothalamic–pituitary–adrenal axis in critical illness

References

• Selye H. A syndrome produced by diverse noxious agents. Nature138, 32 (1936).
   Web of Science ®Google Scholar
• Venkataraman S, Munoz R, Candido C, Witchel SF. The hypothalamic–pituitary–adrenal axis in critical illness. Rev. Endocr. Metab. Disord.8(4), 365–373 (2007).
   PubMedGoogle Scholar
• Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N. Engl. J. Med.348(8), 727–734 (2003).
   PubMed Web of Science ®Google Scholar
• Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J. Clin. Endocrinol. Metab.80(4), 1238–1242 (1995).
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E. Prognostic value of cortisol response in septic shock. JAMA284(3), 308–309 (2000).
   PubMedGoogle Scholar
• Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest122(5), 1784–1796 (2002).
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J. Clin. Endocrinol. Metab.83(6), 1827–1834 (1998).
   PubMed Web of Science ®Google Scholar
• Mesotten D, Vanhorebeek I, Van den Berghe G. The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat. Clin. Pract. Endocrinol. Metab.4(9), 496–505 (2008).
   PubMedGoogle Scholar
• Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol. Metab. Clin. North Am.34(2), 293–313 (2005).
   PubMed Web of Science ®Google Scholar
• Cooper MS, Stewart PM. Adrenal insufficiency in critical illness. J. Intensive Care Med.22(6), 348–362 (2007).
   PubMedGoogle Scholar
• Ghayee HK, Auchus RJ. Basic concepts and recent developments in human steroid hormone biosynthesis. Rev. Endocr. Metab. Disord.8(4), 289–300 (2007).
   PubMed Web of Science ®Google Scholar
• Habib KE, Gold PW, Chrousos GP. Neuroendocrinology of stress. Endocrinol. Metab. Clin. North Am.30(3), 695–728 (2001).
   PubMed Web of Science ®Google Scholar
• Chrousos GP. The hypothalamic–pituitary–adrenal axis and immune-mediated inflammation. N. Engl. J. Med.332(20), 1351–1362 (1995).
   PubMed Web of Science ®Google Scholar
• Miller DB, O’Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism51(1), 5–10 (2002).
   PubMed Web of Science ®Google Scholar
• Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J. Clin. Endocrinol. Metab.91(10), 3725–3745 (2006).
   PubMed Web of Science ®Google Scholar
• Marik PE. Mechanisms and clinical consequences of critical illness associated adrenal insufficiency. Curr. Opin Crit. Care13(4), 363–369 (2007).
   PubMed Web of Science ®Google Scholar
• Arlt W, Hammer F, Sanning P et al. Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J. Clin. Endocrinol. Metab.91(7), 2548–2554 (2006).
   PubMed Web of Science ®Google Scholar
• Esteban NV, Loughlin T, Yergey AL et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J. Clin. Endocrinol. Metab.72(1), 39–45 (1991).
   PubMed Web of Science ®Google Scholar
• Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J. Clin. Endocrinol. Metab.89(1), 281–287 (2004).
   PubMed Web of Science ®Google Scholar
• Loriaux DL. The adrenal cortex. In: Cecil’s Textbook of Medicine. Goldman L, Ausiello D (Eds). Saunders Co., Philadelphia, PA, USA, 1412–1418 (2004).
   Google Scholar
• Venkatesh B, Cohen J, Hickman I et al. Evidence of altered cortisol metabolism in critically ill patients: a prospective study. Intensive Care Med.33(10), 1746–1753 (2007).
   PubMedGoogle Scholar
• Hammond GL, Smith CL, Paterson NA, Sibbald WJ. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J. Clin. Endocrinol. Metab.71(1), 34–39 (1990).
   PubMed Web of Science ®Google Scholar
• Brien TG. Human corticosteroid binding globulin. Clin. Endocrinol. (Oxf.)14(2), 193–212 (1981).
   PubMedGoogle Scholar
• Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N. Engl. J. Med.350(16), 1629–1638 (2004).
   PubMedGoogle Scholar
• Rogerson FM, Fuller PJ. Interdomain interactions in the mineralocorticoid receptor. Mol. Cell. Endocrinol.200(1–2), 45–55 (2003).
   PubMedGoogle Scholar
• Morita H, Isomura Y, Mune T et al. Plasma cortisol and cortisone concentrations in normal subjects and patients with adrenocortical disorders. Metabolism53(1), 89–94 (2004).
   PubMedGoogle Scholar
• White PC, Mune T, Agarwal AK. 11 β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev.18(1), 135–156 (1997).
   PubMed Web of Science ®Google Scholar
• Palermo M, Gomez-Sanchez C, Roitman E, Shackleton CH. Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography/mass spectrometry with stable isotope-labeled internal standards. Steroids61(10), 583–589 (1996).
   PubMedGoogle Scholar
• Kornel L, Miyabo S. Studies on steroid conjugates: IX. Urinary excretion of sulfate conjugated metabolites of cortisol in man. Steroids25(6), 697–706 (1975).
   PubMedGoogle Scholar
• Oelkers W. Adrenal insufficiency. N. Engl. J. Med.335(16), 1206–1212 (1996).
   PubMed Web of Science ®Google Scholar
• Prigent H, Maxime V, Annane D. Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit. Care8(4), 243–252 (2004).
   PubMed Web of Science ®Google Scholar
• Collins S, Caron MG, Lefkowitz RJ. β-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J. Biol. Chem.263(19), 9067–9070 (1988).
   PubMed Web of Science ®Google Scholar
• Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the α 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J. Clin. Invest.88(2), 385–389 (1991).
   PubMed Web of Science ®Google Scholar
• Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N. Engl. J. Med.337(18), 1285–1292 (1997).
   PubMed Web of Science ®Google Scholar
• Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology187(3–5), 403–416 (1993).
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev.21(1), 55–89 (2000).
   PubMed Web of Science ®Google Scholar
• van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia – a clinical research center study. J. Clin. Endocrinol. Metab.81(10), 3604–3606 (1996).
   PubMed Web of Science ®Google Scholar
• Naito Y, Fukata J, Tamai S et al. Biphasic changes in hypothalamo–pituitary–adrenal function during the early recovery period after major abdominal surgery. J. Clin. Endocrinol. Metab.73(1), 111–117 (1991).
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature365(6448), 756–759 (1993).
   PubMed Web of Science ®Google Scholar
• Flaster H, Bernhagen J, Calandra T, Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol.21(6), 1267–1280 (2007).
   PubMed Web of Science ®Google Scholar
• Beishuizen A, Thijs LG, Haanen C, Vermes I. Macrophage migration inhibitory factor and hypothalamo–pituitary–adrenal function during critical illness. J. Clin. Endocrinol. Metab.86(6), 2811–2816 (2001).
   PubMed Web of Science ®Google Scholar
• Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann. Intern. Med.141(1), 47–56 (2004).
   PubMed Web of Science ®Google Scholar
• Keh D, Sprung CL. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit. Care Med.32(11), 527–533 (2004).
   PubMedGoogle Scholar
• Burchard K. A review of the adrenal cortex and severe inflammation: quest of the ‘eucorticoid’ state. J. Trauma51(4), 800–814 (2001).
   PubMed Web of Science ®Google Scholar
• Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab.19(5), 175–180 (2008).
   PubMed Web of Science ®Google Scholar
• Cai TQ, Wong B, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A. Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. J. Steroid Biochem. Mol. Biol.77(2–3), 117–122 (2001).
   PubMed Web of Science ®Google Scholar
• Ho JT, Al-Musalhi H, Chapman MJ et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J. Clin. Endocrinol. Metab.91(1), 105–114 (2006).
   PubMed Web of Science ®Google Scholar
• Bateman A, Singh A, Kral T, Solomon S. The immune–hypothalamic–pituitary–adrenal axis. Endocr. Rev.10(1), 92–112 (1989).
   PubMed Web of Science ®Google Scholar
• Gaillard RC, Turnill D, Sappino P, Muller AF. Tumor necrosis factor α inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology127(1), 101–106 (1990).
   PubMed Web of Science ®Google Scholar
• Richards ML, Caplan RH, Wickus GG, Lambert PJ, Kisken WA. The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: results in elderly subjects after major abdominal surgery. Surgery125(4), 431–440 (1999).
   PubMedGoogle Scholar
• Soni A, Pepper GM, Wyrwinski PM et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am. J. Med.98(3), 266–271 (1995).
   PubMed Web of Science ®Google Scholar
• Sam S, Corbridge TC, Mokhlesi B, Comellas AP, Molitch ME. Cortisol levels and mortality in severe sepsis. Clin. Endocrinol. (Oxf.)60(1), 29–35 (2004).
   PubMedGoogle Scholar
• Melby JC, Spink WW. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J. Clin. Invest.37(12), 1791–1798 (1958).
   PubMed Web of Science ®Google Scholar
• Thompson BT. Glucocorticoids and acute lung injury. Crit. Care Med.31(4), 253–257 (2003).
   PubMed Web of Science ®Google Scholar
• Vogeser M, Groetzner J, Küpper C, Briegel J. The serum cortisol:cortisone ratio in the postoperative acute-phase response. Horm. Res.59(6), 293–296 (2003).
   PubMedGoogle Scholar
• Hardy RS, Filer A, Cooper MS et al. Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis. Res. Ther.8(4), R108 (2006).
   PubMed Web of Science ®Google Scholar
• Loisa P, Rinne T, Kaukinen S. Adrenocortical function and multiple organ failure in severe sepsis. Acta Anaesthesiol. Scand.46(2), 145–151 (2002).
   PubMedGoogle Scholar
• Cole TJ, Blendy JA, Monaghan AP et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev.9(13), 1608–1621 (1995).
   PubMed Web of Science ®Google Scholar
• Reichardt HM, Umland T, Bauer A, Kretz O, Schütz G. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell Biol.20(23), 9009–9017 (2000).
   PubMed Web of Science ®Google Scholar
• Cohen J, Deans R, Dalley A, Lipman J, Roberts MS, Venkatesh B. Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation. Crit. Care13(6), R189 (2009).
   PubMed Web of Science ®Google Scholar
• Adem PV, Montgomery CP, Husain AN et al.Staphylococcus aureussepsis and the Waterhouse-Friderichsen syndrome in children. N. Engl. J. Med.353(12), 1245–1251 (2005).
   PubMed Web of Science ®Google Scholar
• Seidenwurm DJ, Elmer EB, Kaplan LM, Williams EK, Morris DG, Hoffman AR. Metastases to the adrenal glands and the development of Addison’s disease. Cancer54(3), 552–557 (1984).
   PubMed Web of Science ®Google Scholar
• Norbiato G, Galli M, Righini V, Moroni M. The syndrome of acquired glucocorticoid resistance in HIV infection. Baillieres Clin. Endocrinol. Metab.8(4), 777–787 (1994).
   PubMedGoogle Scholar
• Aimaretti G, Ambrosio MR, Di Somma C et al. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin. Endocrinol. (Oxf.)61(3), 320–326 (2004).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Unluhizarci K, Coksevim B, Selcuklu A, Casanueva FF, Kelestimur F. Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin. Endocrinol. (Oxf.)66(3), 360–366 (2007).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. Transient hypogonadotropic hypogonadism in an amateur kickboxer after head trauma. J. Endocrinol. Invest.30(2), 150–152 (2007).
   PubMedGoogle Scholar
• Tanriverdi F, Ulutabanca H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. Pituitary functions in the acute phase of traumatic brain injury: are they related to severity of the injury or mortality? Brain Inj.21(4), 433–439 (2007).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Ulutabanca H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. Three years prospective investigation of anterior pituitary function after traumatic brain injury: a pilot study. Clin. Endocrinol. (Oxf.)68(4), 573–579 (2008).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Dagli AT, Karaca Z et al. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin. Endocrinol. (Oxf.)67(6), 931–937 (2007).
   PubMed Web of Science ®Google Scholar
• Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am. J. Respir. Crit. Care Med.174(12), 1319–1326 (2006).
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet337(8741), 582–583 (1991).
   PubMed Web of Science ®Google Scholar
• Aygen B, Inan M, Doğanay M, Kelestimur F. Adrenal functions in patients with sepsis. Exp. Clin. Endocrinol. Diabetes105(3), 182–186 (1997).
   PubMed Web of Science ®Google Scholar
• Bouachour G, Roy PM, Guiraud MP. The repetitive short corticotropin stimulation test in patients with septic shock. Ann. Intern. Med.123(12), 962–963 (1995).
   PubMed Web of Science ®Google Scholar
• Briegel J, Forst H, Haller M et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit. Care Med.27(4), 723–732 (1999).
   PubMed Web of Science ®Google Scholar
• Annane D, Sébille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA288(7), 862–871 (2002).
   PubMed Web of Science ®Google Scholar
• Burry LD, Wax RS. Role of corticosteroids in septic shock. Ann. Pharmacother.38(3), 464–472 (2004).
   PubMedGoogle Scholar
• Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit. Care Med.31(1), 141–145 (2003).
   PubMed Web of Science ®Google Scholar
• Thorn GW, Forsham PH, Prunty FTG et al. A test for adrenal cortical insufficiency; the response to pituitary andrenocorticotropic hormone. JAMA137(12), 1005–1009 (1948).
   PubMed Web of Science ®Google Scholar
• Beishuizen A, Vermes I, Hylkema BS, Haanen C. Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet353(9165), 1675–1676 (1999).
   PubMedGoogle Scholar
• Pestaña D, Martinez-Casanova E, Buño A, Madero R, Criado A; REASEP sepsis study group. Baseline cortisol levels, total proteins, and eosinophil count as predictors of hemodynamic response to steroid treatment in septic shock. J. Trauma66(4), 1060–1064 (2009).
   PubMedGoogle Scholar
• Reincke M, Allolio B, Würth G, Winkelmann W. The hypothalamic–pituitary–adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J. Clin. Endocrinol. Metab.77(1), 151–156 (1993).
   PubMed Web of Science ®Google Scholar
• Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL. A rational approach for assessing the hypothalamo–pituitary–adrenal axis. Lancet1(8596), 1208–1210 (1988).
   PubMed Web of Science ®Google Scholar
• Widmer IE, Puder JJ, König C et al. Cortisol response in relation to the severity of stress and illness. J. Clin. Endocrinol. Metab.90(8), 4579–4586 (2005).
   PubMed Web of Science ®Google Scholar
• Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA283(8), 1038–1045 (2000).
   PubMed Web of Science ®Google Scholar
• Dickstein G. High-dose and low-dose cosyntropin stimulation tests for diagnosis of adrenal insufficiency. Ann. Intern. Med.140(4), 312–313 (2004).
   PubMedGoogle Scholar
• Siraux V, De Backer D, Yalavatti G et al. Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests. Crit. Care Med.33(11), 2479–2486 (2005).
   PubMed Web of Science ®Google Scholar
• Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P. The short Synacthen and insulin stress tests in the assessment of the hypothalamic–pituitary–adrenal axis. Clin. Endocrinol. (Oxf.)44(2), 141–146 (1996).
   PubMedGoogle Scholar
• Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo–pituitary–adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clin. Endocrinol. (Oxf.)52(5), 633–640 (2000).
   PubMedGoogle Scholar
• Moran JL, Chapman MJ, O’Fathartaigh MS, Peisach AR, Pannall PR, Leppard P. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med.20(7), 489–495 (1994).
   PubMed Web of Science ®Google Scholar
• Rivers EP, Gaspari M, Saad GA et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest119(3), 889–896 (2001).
   PubMedGoogle Scholar
• Annane D. Time for a consensus definition of corticosteroid insufficiency in critically ill patients. Crit. Care Med.31(6), 1868–1869 (2003).
   PubMedGoogle Scholar
• Marik PE, Pastores SM, Annane D et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit. Care Med.36(6), 1937–1949 (2008).
   PubMed Web of Science ®Google Scholar
• Sarthi M, Lodha R, Vivekanandhan S, Arora NK. Adrenal status in children with septic shock using low-dose stimulation test. Pediatr. Crit. Care Med.8(1), 23–28 (2007).
   PubMedGoogle Scholar
• Briegel J, Sprung CL, Annane D et al.; CORTICUS Study Group. Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med.35(12), 2151–2156 (2009).
   PubMedGoogle Scholar
• Bolland MJ, Chiu WW, Davidson JS, Croxson MS. Heterophile antibodies may cause falsely lowered serum cortisol values. J. Endocrinol. Invest.28(7), 643–645 (2005).
   PubMedGoogle Scholar
• Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med.27(10), 1584–1591 (2001).
   PubMed Web of Science ®Google Scholar
• le Roux CW, Chapman GA, Kong WM, Dhillo WS, Jones J, Alaghband-Zadeh J. Free cortisol index is better than serum total cortisol in determining hypothalamic–pituitary–adrenal status in patients undergoing surgery. J. Clin. Endocrinol. Metab.88(5), 2045–2048 (2003).
   PubMedGoogle Scholar
• Bendel S, Karlsson S, Pettilä V, Loisa P, Varpula M, Ruokonen E; Finnsepsis Study Group. Free cortisol in sepsis and septic shock. Anesth. Analg.106(6), 1813–1819 (2008).
   PubMed Web of Science ®Google Scholar
• Cohen J, Venkatesh B, Galligan J, Thomas P. Salivary cortisol concentration in the intensive care population: correlation with plasma cortisol values. Anaesth. Intensive Care.32(6), 843–845 (2004).
   PubMedGoogle Scholar
• Loisa P, Uusaro A, Ruokonen E. A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock. Anesth. Analg.101(6), 1792–1798 (2005).
   PubMed Web of Science ®Google Scholar
• Balk RA. Steroids for septic shock: back from the dead? (Pro). Chest123(5), 490S–499S (2003).
   Google Scholar
• Russell JA. Management of sepsis. N. Engl. J. Med.355(16), 1699–1713 (2006).
   PubMed Web of Science ®Google Scholar
• Hinshaw LB, Solomon LA, Freeny PC, Reins DA. Endotoxin shock. Hemodynamic and survival effects of methylprednisolone. Arch. Surg.94(1), 61–66 (1967).
   PubMedGoogle Scholar
• Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit. Care Med.25(7), 1095–1100 (1997).
   PubMed Web of Science ®Google Scholar
• Yildiz O, Doganay M, Aygen B, Güven M, Keleştimur F, Tutus A. Physiological-dose steroid therapy in sepsis. Crit. Care6(3), 251–259 (2002).
   PubMedGoogle Scholar
• Altura BM, Altura BT. Peripheral vascular actions of glucocorticoids and their relationship to protection in circulatory shock. J. Pharmacol. Exp. Ther.190(2), 300–315 (1974).
   PubMedGoogle Scholar
• Annane D, Bellissant E, Bollaert PE et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA301(22), 2362–2375 (2009).
   PubMed Web of Science ®Google Scholar
• Minneci PC, Deans KJ, Eichacker PQ, Natanson C. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin. Microbiol. Infect.15(4), 308–318 (2009).
   PubMed Web of Science ®Google Scholar
• Minneci PC, Deans KJ, Natanson C. Corticosteroid therapy for severe sepsis and septic shock. JAMA302(15), 1643–1645 (2009).
   PubMedGoogle Scholar
• Sprung CL, Annane D, Keh D et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med.358(2), 111–124 (2008).
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med.36(1), 296–327 (2008).
   PubMed Web of Science ®Google Scholar
• Weis F, Beiras-Fernandez A, Schelling G et al. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit. Care Med.37(5), 1685–1690 (2009).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley AS, Golden E et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA280(2), 159–165 (1998).
   PubMed Web of Science ®Google Scholar
• Confalonieri M, Urbino R, Potena A et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am. J. Respir. Crit. Care Med.171(3), 242–248 (2005).
   PubMed Web of Science ®Google Scholar
• Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann. Surg.219(4), 416–425 (1994).
   PubMed Web of Science ®Google Scholar
• Steinberg KP, Hudson LD, Goodman RB et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N. Engl. J. Med.354(16), 1671–1684 (2006).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Golden E, Freire AX et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest131(4), 954–963 (2007).
   PubMed Web of Science ®Google Scholar
• Agha A, Rogers B, Sherlock M et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J. Clin. Endocrinol. Metab.89(10), 4929–4936 (2004).
   PubMed Web of Science ®Google Scholar
• Tanriverdi F, Senyurek H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J. Clin. Endocrinol. Metab.91(6), 2105–2111 (2006).
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Tsagarakis S. Hypothalamic–pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury. Intensive Care Med.31(8), 1020–1028 (2005).
   PubMed Web of Science ®Google Scholar
• Kokshoorn NE, Wassenaar MJ, Biermasz NR et al. Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values. Eur. J. Endocrinol.162(1), 11–18 (2010).
   PubMed Web of Science ®Google Scholar
• Llompart-Pou JA, Raurich JM, Pérez-Bárcena J, Barceló A, Ibáñez J, Ayestarán JI. Acute hypothalamic–pituitary–adrenal response in traumatic brain injury with and without extracerebral trauma. Neurocrit. Care9(2), 230–236 (2008).
   PubMedGoogle Scholar
• Dimopoulou I, Tsagarakis S, Douka E et al. The low-dose corticotropin stimulation test in acute traumatic and non-traumatic brain injury: incidence of hypo-responsiveness and relationship to outcome. Intensive Care Med.30(6), 1216–1219 (2004).
   PubMed Web of Science ®Google Scholar
• Cohan P, Wang C, McArthur DL et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit. Care Med.33(10), 2358–2366 (2005).
   PubMed Web of Science ®Google Scholar
• Schwarz S, Schwab S, Klinga K, Maser-Gluth C, Bettendorf M. Neuroendocrine changes in patients with acute space occupying ischaemic stroke. J. Neurol. Neurosurg. Psychiatry74(6), 725–727 (2003).
   PubMed Web of Science ®Google Scholar
• Roberts I, Yates D, Sandercock P et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet364(9442), 1321–1328 (2004).
   PubMed Web of Science ®Google Scholar
• Offner PJ, Moore EE, Ciesla D. The adrenal response after severe trauma. Am. J. Surg.184(6), 649–653 (2002).
   PubMed Web of Science ®Google Scholar
• Skillman JJ, Lauler DP, Hickler RB et al. Hemorrhage in normal man: effect on renin, cortisol, aldosterone, and urine composition. Ann. Surg.166(6), 865–885 (1967).
   PubMed Web of Science ®Google Scholar
• Pene F, Hyvernat H, Mallet V et al. Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest. Intensive Care Med.31(5), 627–633 (2005).
   PubMedGoogle Scholar